MENUNews Archive
Date: 02/10/2015
A set of guidelines developed to help standardized lung cancer screening would have generated considerably fewer false-positives than the National Lung Screening Trial produced, according to a new retrospective study.
Date: 02/06/2015
The Centers for Medicare and Medicaid Services have finalized coverage guidelines for lung cancer screening with CT scans for people at high-risk of developing lung cancer. Coverage goes into effect immediately.
Date: 01/28/2015
A new study from researchers at the University of Michigan Rogel Cancer Center sheds light on the KRAS pathway with a potential target that might have more success at stopping lung cancer growth.
Date: 01/22/2015
Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™, 800-865-1125
Date: 01/20/2015
Researchers at the University of Michigan Rogel Cancer Center analyzed the global landscape of a portion of the genome that has not been previously well-explored. This analysis opens the door to discovery of thousands of potential new cancer biomarkers.
Date: 01/16/2015
A new study characterizes the genetic underpinnings of a rare type of breast tumor called phyllodes tumors, offering the first comprehensive analysis of the molecular alterations at work in these tumors.
Date: 01/15/2015
Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine, 800-865-1125
Date: 01/07/2015
One of the mysteries in cancer biology is how one protein, TGF-beta, can both stop cancer from forming and encourage its aggressive growth. Now, researchers at the University of Michigan Rogel Cancer Center have uncovered a key gene that may explain this paradox and provide a potential target for treatment.
Date: 12/22/2014
By analyzing the DNA and RNA of lung cancers, researchers at the University of Michigan Rogel Cancer Center found that patients whose tumors contained a large number of gene fusions had worse outcomes than patients with fewer gene fusions.
Date: 12/19/2014
In a development that could lead to a deeper understanding of cancer and better early-stage treatment of the disease, University of Michigan researchers have devised a reliable way to grow a certain type of cancer cells from patients outside the body for study.